One of the most likely vaccine candidates for the corona virus vaccine, the US pharmaceutical company Pfizer Inc, has a big claim on the vaccine. The company said that the Phase III study of our Covid-19 vaccine has met all the key points. The study reached 170 confirmed cases of Kovid-19. The vaccine candidate BNT163B2 (BNT162b2) showed a 95% effective onset 28 days after the first dose.
Pfizer’s Phase III Study Demostrate 95% Efficacy
Date:
More like thisRelated
A Global Perspective of Assistive Technology for Differently-Abled People (Divyangjan)
Assistive technology plays a crucial role in empowering individuals...
An Ugly Reality: Disrespect Towards Artists in Tollywood
Bengal Film Industry (Tollywood) has again witnessed an incident...
We Need New Parliament Ethos Before A New Parliament Building
9 years ago, when Narendra Modi and his party...
